{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:00:32Z","timestamp":1791064832597,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T00:00:00Z","timestamp":1333065600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034230","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T21:15:52Z","timestamp":1333142152000},"page":"e34230","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO\/PKG Pathway in the Bile-Duct-Ligated Rat"],"prefix":"10.1371","volume":"7","author":[{"given":"Wei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Li","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Qiu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yuan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension.","volume":"32","author":"J Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/01.mcg.0000155552.14396.3d","article-title":"Portal hypertension: from bedside to bench.","volume":"39","author":"RJ Groszmann","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1665-2681(19)31950-7","article-title":"Current concepts on the pathophysiology of portal hypertension.","volume":"6","author":"A Rodriguez-Vilarrupla","year":"2007","journal-title":"Ann Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis.","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers in portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase.","volume":"46","author":"J Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.","volume":"150","author":"JR Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2006.07.011","article-title":"Angiotensin II and aldosterone stimulating NF-\u03baB and AP-1 activation in hepatic fibrosis of rat.","volume":"138","author":"X Li","year":"2009","journal-title":"Regul Pept"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.trsl.2006.03.007","article-title":"Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.","volume":"148","author":"G Fujisawa","year":"2006","journal-title":"Transl Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2010.03.013","article-title":"Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis.","volume":"53","author":"P Tandon","year":"2010","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.","volume":"35","author":"R Wiest","year":"2002","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.regpep.2011.04.010","article-title":"Aldosterone induction of hepatic stellate cell contraction through activation of RhoA\/ROCK-2 signaling pathway.","volume":"169","author":"H Ji","year":"2011","journal-title":"Regul Pept"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","article-title":"Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver.","volume":"123","author":"G Paizis","year":"2002","journal-title":"Gastroenterology"},{"key":"ref13","first-page":"305","article-title":"Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat.","volume":"65","author":"J Kountouras","year":"1984","journal-title":"Br J Exp Pathol"},{"issue":"1","key":"ref14","first-page":"64","article-title":"Gene-CYP11B2 expression in rat liver in hepatic fibrogenesis induced by CCl4.","volume":"114","author":"X Li","year":"2001","journal-title":"Chin Med J (Engl)"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.22170","article-title":"Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.","volume":"47","author":"J Trebicka","year":"2008","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.3748\/wjg.v12.i39.6376","article-title":"Dynamic expression of extracellular signal-regulated kinase in rat liver tissue during hepatic fibrogenesis.","volume":"12","author":"XL Zhang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0016-5085(99)70461-0","article-title":"Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.","volume":"117","author":"H Miyoshi","year":"1999","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.RES.87.11.999","article-title":"Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide\/cGMP signaling and endothelial dysfunction.","volume":"87","author":"M Oelze","year":"2000","journal-title":"Circ Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoA\/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.","volume":"130","author":"M Hennenberg","year":"2006","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","article-title":"Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.","volume":"55","author":"Q Zhou","year":"2006","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"G328","DOI":"10.1152\/ajpgi.00367.2005","article-title":"Roles of anandamide in the hepatic microcirculation in cirrhotic rats.","volume":"290","author":"YY Yang","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref22","first-page":"46","article-title":"Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.","volume":"86","author":"H Okumura","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.510230517","article-title":"The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites.","volume":"23","author":"F Nevens","year":"1996","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0168-8278(00)00087-8","article-title":"Effect of aldosterone on collagen steady state levels in primary and subcultured rat hepatic stellate cells.","volume":"34","author":"K Rombouts","year":"2001","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/gast.2003.50058","article-title":"Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.","volume":"124","author":"A Caligiuri","year":"2003","journal-title":"Gatoroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2008.05.069","article-title":"Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.","volume":"372","author":"J Yu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/jhep.2001.21998","article-title":"Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver.","volume":"33","author":"KE Wack","year":"2001","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.50.4.571","article-title":"Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.","volume":"50","author":"H Reynaert","year":"2002","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis.","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21564","article-title":"Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?","volume":"45","author":"JS Lee","year":"2007","journal-title":"Hepatology"},{"key":"ref31","first-page":"288","article-title":"CYP11B2 expression in rat liver and the effect of spironolactone on hepatic fibrogenesis.","volume":"53","author":"X Yang","year":"2000","journal-title":"Horm Res"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.","volume":"151","author":"T Wada","year":"2010","journal-title":"Endocrinology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis.","volume":"105","author":"S Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activ-ity.","volume":"13","author":"JA Leopold","year":"2007","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells.","volume":"16","author":"K Miyata","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1523-1755.2004.00913.x","article-title":"Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.","volume":"66","author":"G Fujisawa","year":"2004","journal-title":"Kidney Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress.","volume":"161","author":"Y Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide.","volume":"97","author":"Y Rikitake","year":"2005","journal-title":"Circ Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.22.24.8467-8477.2002","article-title":"Rho GTPase\/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B\/Akt in human endothelial cells.","volume":"22","author":"XF Ming","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"G1006","DOI":"10.1152\/ajpgi.00465.2002","article-title":"Inhibition of sustained mooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA.","volume":"284","author":"KS Murthy","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.","volume":"53","author":"Y Wang","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/labinvest.2010.148","article-title":"Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis.","volume":"91","author":"M Hennenberg","year":"2011","journal-title":"Lab Invest"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2008.04.014","article-title":"Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.","volume":"49","author":"V Matei","year":"2008","journal-title":"J Hepatol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/gut.2008.149880","article-title":"Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.","volume":"58","author":"B Lavi\u00f1a","year":"2009","journal-title":"Gut"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T03:35:12Z","timestamp":1593920112000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034230"}},"subtitle":[],"editor":[{"given":"Kwan","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034230","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]}}}